Pfizer Inc (PFE)
25.98
+0.60
(+2.34%)
USD |
NYSE |
Apr 19, 16:00
25.92
-0.06
(-0.25%)
After-Hours: 20:00
Pfizer Cash from Investing (Quarterly): -11.00B for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -11.00B |
| September 30, 2023 | 888.00M |
| June 30, 2023 | -25.48B |
| March 31, 2023 | 3.315B |
| December 31, 2022 | -4.41B |
| September 30, 2022 | -627.00M |
| June 30, 2022 | -11.31B |
| March 31, 2022 | 567.00M |
| December 31, 2021 | -2.586B |
| September 30, 2021 | -10.08B |
| June 30, 2021 | -8.137B |
| March 31, 2021 | -1.747B |
| December 31, 2020 | 8.33B |
| September 30, 2020 | 481.00M |
| June 30, 2020 | -13.01B |
| March 31, 2020 | -71.00M |
| December 31, 2019 | -2.833B |
| September 30, 2019 | -6.76B |
| June 30, 2019 | -1.902B |
| March 31, 2019 | 7.55B |
| December 31, 2018 | -764.00M |
| September 30, 2018 | -2.904B |
| June 30, 2018 | -1.474B |
| March 31, 2018 | 9.667B |
| December 31, 2017 | -4.759B |
| Date | Value |
|---|---|
| September 30, 2017 | -3.011B |
| June 30, 2017 | -1.738B |
| March 31, 2017 | 4.768B |
| December 31, 2016 | -3.087B |
| September 30, 2016 | -4.381B |
| June 30, 2016 | -4.678B |
| March 31, 2016 | 4.355B |
| December 31, 2015 | -2.224B |
| September 30, 2015 | -5.243B |
| June 30, 2015 | -2.105B |
| March 31, 2015 | 6.592B |
| December 31, 2014 | -1.514B |
| September 30, 2014 | -2.535B |
| June 30, 2014 | -1.507B |
| March 31, 2014 | -98.00M |
| December 31, 2013 | 142.00M |
| September 30, 2013 | -603.00M |
| June 30, 2013 | 843.00M |
| March 31, 2013 | -10.93B |
| December 31, 2012 | 6.837B |
| September 30, 2012 | -247.00M |
| June 30, 2012 | -887.00M |
| March 31, 2012 | 451.00M |
| December 31, 2011 | 542.00M |
| September 30, 2011 | 215.00M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-25.48B
Minimum
Jun 2023
8.33B
Maximum
Dec 2020
-4.546B
Average
-2.586B
Median
Dec 2021
Cash from Investing (Quarterly) Benchmarks
| Amgen Inc | -27.09B |
| Gilead Sciences Inc | -727.00M |
| Johnson & Johnson | -1.202B |
| Viking Therapeutics Inc | 35.73M |
| Moderna Inc | -538.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 5.24B |
| Cash from Financing (Quarterly) | 5.442B |
| Free Cash Flow | 4.793B |
| Free Cash Flow Per Share (Quarterly) | 0.7432 |
| Free Cash Flow to Equity (Quarterly) | -3.053B |
| Free Cash Flow to Firm (Quarterly) | 4.260B |
| Free Cash Flow Yield | 3.25% |